Vicente Miranda et al. revealed that HSP27 led to the generation of nontoxic α-synuclein species by decreasing methylglyoxal-induced cellular α-synuclein aggregation in vitro, thereby regulating the glycation-mediated cellular pathologies in synucleinopathies [32]. Here, HSPB1 is linked to synucleinopathy.